Cellular automata, cancer resistance, tumor heterogeneity, adaptive therapy, AI-assistance, and more.
Share this post
This week in MathOnco 241
Share this post
Cellular automata, cancer resistance, tumor heterogeneity, adaptive therapy, AI-assistance, and more.